SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-22-014674
Filing Date
2022-09-28
Accepted
2022-09-28 09:23:17
Documents
13
Period of Report
2022-05-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A hrmy-20220520x8ka.htm   iXBRL 8-K/A 55489
2 GRAPHIC hrmy-20220520x8ka001.jpg GRAPHIC 1167
  Complete submission text file 0001558370-22-014674.txt   179258

Data Files

Seq Description Document Type Size
3 EX-101.SCH hrmy-20220520.xsd EX-101.SCH 3164
4 EX-101.LAB hrmy-20220520_lab.xml EX-101.LAB 15929
5 EX-101.PRE hrmy-20220520_pre.xml EX-101.PRE 10082
7 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20220520x8ka_htm.xml XML 4881
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39450 | Film No.: 221272928
SIC: 2834 Pharmaceutical Preparations